Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity

RC Gimple, K Yang, ME Halbert, S Agnihotri… - Nature Reviews …, 2022 - nature.com
Malignant brain tumours are complex ecosystems containing neoplastic and stromal
components that generate adaptive and evolutionarily driven aberrant tissues in the central …

Macrophages and microglia: the cerberus of glioblastoma

A Buonfiglioli, D Hambardzumyan - Acta neuropathologica …, 2021 - Springer
Glioblastoma (GBM) is the most aggressive and deadliest of the primary brain tumors,
characterized by malignant growth, invasion into the brain parenchyma, and resistance to …

Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology

T Chu, Z Wang, D Pe'er, CG Danko - Nature Cancer, 2022 - nature.com
Inferring single-cell compositions and their contributions to global gene expression changes
from bulk RNA sequencing (RNA-seq) datasets is a major challenge in oncology. Here we …

EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3

Z Pan, R Zhao, B Li, Y Qi, W Qiu, Q Guo, S Zhang… - Molecular cancer, 2022 - Springer
Background Gliomas are the most common malignant primary brain tumours with a highly
immunosuppressive tumour microenvironment (TME) and poor prognosis. Circular RNAs …

Cancer stemness meets immunity: from mechanism to therapy

P Chen, WH Hsu, J Han, Y Xia, RA DePinho - Cell reports, 2021 - cell.com
Cancer stem cells (CSCs) are self-renewing cells that facilitate tumor initiation, promote
metastasis, and enhance cancer therapy resistance. Transcriptomic analyses across many …

Glioma: molecular signature and crossroads with tumor microenvironment

L Barthel, M Hadamitzky, P Dammann… - Cancer and Metastasis …, 2022 - Springer
In patients with glioblastoma, the average survival time with current treatments is short,
mainly due to recurrences and resistance to therapy. This insufficient treatment success is, in …

Glioblastoma heterogeneity at single cell resolution

D Eisenbarth, YA Wang - Oncogene, 2023 - nature.com
Glioblastoma (GBM) is one of the deadliest types of cancer and highly refractory to
chemoradiation and immunotherapy. One of the main reasons for this resistance to therapy …

The crosstalk between tumor-associated macrophages (TAMs) and tumor cells and the corresponding targeted therapy

Z Ge, S Ding - Frontiers in oncology, 2020 - frontiersin.org
Tumor microenvironment (TME) is composed of tumor cells and surrounding non-tumor
stromal cells, mainly including tumor associated macrophages (TAMs), endothelial cells …

Structural variants drive context-dependent oncogene activation in cancer

Z Xu, DS Lee, S Chandran, VT Le, R Bump, J Yasis… - Nature, 2022 - nature.com
Higher-order chromatin structure is important for the regulation of genes by distal regulatory
sequences,. Structural variants (SVs) that alter three-dimensional (3D) genome organization …

Microglia/brain macrophages as central drivers of brain tumor pathobiology

DH Gutmann, H Kettenmann - Neuron, 2019 - cell.com
One of the most common brain tumors in children and adults is glioma or astrocytoma. There
are few effective therapies for these cancers, and patients with malignant glioma fare poorly …